HERON THERAPEUTICS, INC.
HERON THERAPEUTICS, INC. appears in FDA public data with 1 recall, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1335-2022, Class III) was initiated on August 2, 2022.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1335-2022 | Class III | Zynrelef (bupivacaine and meloxicam), 400 mg bupivacaine and 12 mg meloxicam single dose application | August 2, 2022 |